Skip to main content
Top

Clinical and Translational Oncology

Issue 12/2018

Content (17 Articles)

Review Article

This is a call to oncologists for action

C. Micó, A. Berrocal, A. Blasco, C. Caballero, V. Iranzo, M. Lobo, C. Camps

Review Article

New physical approaches to treat cancer stem cells: a review

H. Ghaffari, J. Beik, A. Talebi, S. R. Mahdavi, H. Abdollahi

Open Access Research Article

Consensus document on the progression and treatment response criteria in gastroenteropancreatic neuroendocrine tumors

X. Merino-Casabiel, J. Aller, J. Arbizu, R. García-Figueiras, C. González, E. Grande, P. Jiménez-Fonseca, M. I. Sevilla, J. Capdevila

Research Article

Delay in starting radiotherapy due to neoadjuvant therapy does not worsen survival in unresected glioblastoma patients

C. Balaña, A. Estival, I. Teruel, M. Hardy-Werbin, J. Sepulveda, E. Pineda, M. Martinez-García, O. Gallego, R. Luque, M. Gil-Gil, C. Mesia, S. Del Barco, A. Herrero, A. Berrocal, P. Perez-Segura, R. De las Penas, J. Marruecos, R. Fuentes, G. Reynes, J. M. Velarde, A. Cardona, E. Verger, C. Panciroli, S. Villà

Research Article

Influence of age on variation in patterns of care in patients with rectal cancer in Catalonia (Spain)

R. Vernet, J. M. Borras, L. Aliste, M. Antonio, A. Guarga, P. Manchon-Walsh

Research Article

Prognostic role for the derived neutrophil-to-lymphocyte ratio in early breast cancer: a GEICAM/9906 substudy

A. J. Templeton, Á. Rodríguez-Lescure, A. Ruíz, E. Alba, L. Calvo, M. Ruíz-Borrego, A. Santaballa, C. A. Rodríguez, C. Crespo, M. Ramos, J. M. Gracia-Marco, A. Lluch, I. Álvarez, M. I. Casas, M. Sánchez-Aragó, R. Caballero, E. Carrasco, E. Amir, M. Martin, A. Ocaña

Open Access Research Article

Radiolabeled F(ab′)2-cetuximab for theranostic purposes in colorectal and skin tumor-bearing mice models

P.-S. Bellaye, M. Moreau, O. Raguin, A. Oudot, C. Bernhard, J.-M. Vrigneaud, L. Dumont, D. Vandroux, F. Denat, A. Cochet, F. Brunotte, B. Collin

Research Article

Choice of antiepileptic drugs affects the outcome in cancer patients with seizures

B. Cacho-Diaz, D. San-Juan, K. Salmeron, C. Boyzo, N. Lorenzana-Mendoza

Research Article

Management of patients with implanted cardiac devices during radiotherapy: results of a Spanish survey in radiation oncology departments

S. Sabater, A. Montero, T. López Fernández, J. J. González Ferrer, M. Arenas

Research Article

Does NEMO/IKKγ protein have a role in determining prognostic significance in uveal melanoma?

M. K. Singh, N. Pushker, R. Meel, K. Chodsol, S. Sen, S. Bakhshi, L. Singh, S. Kashyap

Research Article

Prospective analysis of psychological differences between adult and elderly cancer patients during postoperative adjuvant chemotherapy

M. M. Muñoz-Sánchez, C. Calderon, P. Jimenez-Fonseca, M. C. Soriano-Rodríguez, C. Jara, T. García-García, C. Beato, J. Rogado, B. Castelo, R. Hernández, M. Mangas-Izquierdo, A. Carmona-Bayonas

Brief Research Article

Patterns of increased incidence and survival of cutaneous melanoma in Girona (Spain) 1994–2013: a population-based study

J. Rubió-Casadevall, M. Puig-Vives, M. Puigdemont, L. Vilardell, A. Carbó-Bagué, R. Marcos-Gragera, N. Vilar-Coromina

Correspondence

Letter to the Editor

V. Castel, A. Cañete, I. Calabria, J. Cervera, S. Dolz, P. Escobar, J. Font de Mora, P. Gargallo, G. Llavador, L. Pedrola, Y. Yañez, A. Zuñiga

Correspondence

Incidence and survival of primary central nervous system lymphoma (PCNSL): results from the Girona cancer registry (1994–2013)

R. Fuentes-Raspall, M. Solans, C. Auñon-Sanz, M. Saez, R. Marcos-Gragera

Correction

Correction to: Efficacy of fulvestrant in the treatment of postmenopausal women with endocrine-resistant advanced breast cancer in routine clinical practice

I. Blancas, M. Fontanillas, V. Conde, J. Lao, E. Martínez, M. J. Sotelo, A. Jaen, J. L. Bayo, F. Carabantes, J. J. Illarramendi, M. M. Gordon, J. Cruz, A. García-Palomo, C. Mendiola, E. Pérez-Ruiz, J. S. Bofill, J. M. Baena-Cañada, N. M. Jáñez, G. Esquerdo, M. Ruiz-Borrego

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine